Floatz logo

ptk787

Non-Small Cell Lung Cancer and Pleural Mesothelioma

Nevada Cancer InstitutePhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Non-Small Cell Lung Cancer and Pleural Mesothelioma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Nevada Cancer Institute
Phase 1/2CCC

Same molecule, other indications

ptk787 is also rated in:

neoplasmDormant
BB
Indicative ·
64 / 100
View asset →
rectal neoplasmDormant
B
Indicative ·
60 / 100
View asset →
colonic neoplasmDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →